Patient-tailored artificial heart device
While end-stage heart failure affects millions of people annually, only a few patients have access to cardiac transplantation due to donor shortage. Mechanical circulatory support (MCS) is a long-term solution, but external power needs lead to driveline infections and massive systems that limit patient mobility. Ventricular assist devices (VAD) can drive MCS by transferring the available cardiovascular energy to the diseased site without external power support. The EU-funded BloodTurbine project will complete the optimisation of VAD, performing comparative analysis and preclinical experiments in line with the new medical devices regulatory framework as well as business development, valuation and intellectual property rights activities. Project results will lead to a new patient-tailored VAD concept.
Fields of science
Funding SchemeERC-POC-LS - ERC Proof of Concept Lump Sum Pilot
See on map